Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("DETKE, Michael J")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 29

  • Page / 2
Export

Selection :

  • and

Duloxetine vs. placebo in patients with painful diabetic neuropathyGOLDSTEIN, David J; YILI LU; DETKE, Michael J et al.Pain (Amsterdam). 2005, Vol 116, Num 1-2, pp 109-118, issn 0304-3959, 10 p.Article

The dual transporter inhibitor duloxetine: A review of its preclinical pharmacology, pharmacokinetic profile, and clinical results in depression : Novel antidepressants/anxiolyticsBYMASTER, Frank P; LEE, Thomas C; KNADLER, Mary Pat et al.Current pharmaceutical design. 2005, Vol 11, Num 12, pp 1475-1493, issn 1381-6128, 19 p.Article

Duloxetine 60 mg once daily dosing versus placebo in the acute treatment of major depressionDETKE, Michael J; YILI LU; GOLDSTEIN, David J et al.Journal of psychiatric research. 2002, Vol 36, Num 6, pp 383-390, issn 0022-3956Article

Duloxetine, 60 mg once daily, for major depressive disorder: A randomized double-blind placebo-controlled trialDETKE, Michael J; YILI LU; GOLDSTEIN, David J et al.The Journal of clinical psychiatry. 2002, Vol 63, Num 4, pp 308-315, issn 0160-6689Article

Management of depression relapse : Re-initiation of duloxetine treatment or dose increaseFAVA, Maurizio; DETKE, Michael J; BALESTRIERI, Matteo et al.Journal of psychiatric research. 2006, Vol 40, Num 4, pp 328-336, issn 0022-3956, 9 p.Article

Evidence for the efficacy of duloxetine in treating mild, moderate, and severe depressionSHELTON, Richard C; ANDORN, Anne C; MALLINCKRODT, Craig H et al.International clinical psychopharmacology. 2007, Vol 22, Num 6, pp 348-355, issn 0268-1315, 8 p.Article

Cardiovascular profile of duloxetine, a dual reuptake inhibitor of serotonin and norepinephrineTHASE, Michael E; TRAN, Pierre V; WILTSE, Curtis et al.Journal of clinical psychopharmacology. 2005, Vol 25, Num 2, pp 132-140, issn 0271-0749, 9 p.Article

The effect of duloxetine on painful physical symptoms in depressed patients: Do improvements in these symptoms result in higher remission rates?FAVA, Maurizio; MALLINCKRODT, Craig H; DETKE, Michael J et al.The Journal of clinical psychiatry. 2004, Vol 65, Num 4, pp 521-530, issn 0160-6689, 10 p.Article

Serotonergic mediation of the effects of fluoxetine, but not desipramine, in the rat forced swimming testPAGE, Michelle E; DETKE, Michael J; DALVI, Ashutosh et al.Psychopharmacologia. 1999, Vol 147, Num 2, pp 162-167, issn 0033-3158Article

Is PTSD caused by traumatic stress?BODKIN, J. Alexander; POPE, Harrison G; DETKE, Michael J et al.Journal of anxiety disorders. 2007, Vol 21, Num 2, pp 176-182, issn 0887-6185, 7 p.Article

Is treatment-associated hypomania rare with duloxetine : Secondary analysis of controlled trials in non-bipolar depressionDUNNER, David L; D'SOUZA, Deborah N; KAJDASZ, Daniel K et al.Journal of affective disorders. 2005, Vol 87, Num 1, pp 115-119, issn 0165-0327, 5 p.Article

Efficacy and safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disorder : Results from a 6-month, randomized, double-blind, placebo-controlled, fixed-dose trialRUSSELL, I. Jon; MEASE, Philip J; SMITH, Timothy R et al.Pain (Amsterdam). 2008, Vol 136, Num 3, pp 432-444, issn 0304-3959, 13 p.Article

Effects of duloxetine on painful physical symptoms associated with depressionGOLDSTEIN, David J; YILI LU; DETKE, Michael J et al.Psychosomatics (Washington, DC). 2004, Vol 45, Num 1, pp 17-28, issn 0033-3182, 12 p.Article

Clinical evidence for serotonin and norepinephrine reuptake inhibition of duloxetineTRIVEDI, Madhukar H; DESAIAH, Durisala; OSSANNA, Melissa J et al.International clinical psychopharmacology. 2008, Vol 23, Num 3, pp 161-169, issn 0268-1315, 9 p.Article

Efficacy of duloxetine and selective serotonin reuptake inhibitors : Comparisons as assessed by remission rates in patients with major depressive disorderTHASE, Michael E; LU PRITCHETT, Yili; OSSANNA, Melissa J et al.Journal of clinical psychopharmacology. 2007, Vol 27, Num 6, pp 672-676, issn 0271-0749, 5 p.Article

Duloxetine in the prevention of relapse of major depressive disorder : Double-blind placebo-controlled studyPERAHIA, David G; GILABERTE, Inmaculada; FUJUN WANG et al.British journal of psychiatry (Print). 2006, Vol 188, Num AVR, pp 346-353, issn 0007-1250, 8 p.Article

Duloxetine in the treatment of depression: A double-blind placebo-controlled comparison with paroxetineGOLDSTEIN, David J; YILI LU; DETKE, Michael J et al.Journal of clinical psychopharmacology. 2004, Vol 24, Num 4, pp 389-399, issn 0271-0749, 11 p.Article

Antidepressant-like effects of cytidine in the forced swim test in ratsCARLEZON, William A; PLIAKAS, Andrea M; PAROW, Aimee M et al.Biological psychiatry (1969). 2002, Vol 51, Num 11, pp 882-889, issn 0006-3223Article

A 6-week randomized, double-blind, placebo-controlled, comparator referenced trial of vabicaserin in acute schizophreniaSHEN, Joan H. Q; YONGGANG ZHAO; ROSENZWEIG-LIPSON, Sharon et al.Journal of psychiatric research. 2014, Vol 53, pp 14-22, issn 0022-3956, 9 p.Article

Duloxetine in the Prevention of Depressive Recurrences: A Randomized, Double-Blind, Placebo-Controlled TrialPERAHIA, David G. S; MAINA, Giuseppe; THASE, Michael E et al.The Journal of clinical psychiatry. 2009, Vol 70, Num 5, issn 0160-6689, 706-716 [11 p.]Article

Duloxetine for the treatment of major depressive disorder in women ages 40 to 55 yearsBURT, Vivien K; WOHLREICH, Madelaine M; MALLINCKRODT, Craig H et al.Psychosomatics (Washington, DC). 2005, Vol 46, Num 4, pp 345-354, issn 0033-3182, 10 p.Article

Long-Term Safety, Tolerability, and Efficacy of Duloxetine in the Treatment of FibromyalgiaMEASE, Philip J; RUSSELL, I. Jon; KAJDASZ, Daniel K et al.Seminars in arthritis and rheumatism. 2010, Vol 39, Num 6, pp 454-464, issn 0049-0172, 11 p.Article

Evaluating the maintenance of effect of duloxetine in patients with diabetic peripheral neuropathic painSKLJAREVSKI, Vladimir; DESAIAH, Durisala; QI ZHANG et al.Diabetes/metabolism research and reviews (Print). 2009, Vol 25, Num 7, pp 623-631, issn 1520-7552, 9 p.Article

A Randomized, Double-Blind Study of Increasing or Maintaining Duloxetine Dose in Patients Without Remission of Major Depressive Disorder After Initial Duloxetine TherapyKORNSTEIN, Susan G; DUNNER, David L; MEYERS, Adam L et al.The Journal of clinical psychiatry. 2008, Vol 69, Num 9, pp 1383-1392, issn 0160-6689, 10 p.Article

Duloxetine treatment for role functioning improvement in generalized anxiety disorder : Three independent studiesENDICOTT, Jean; RUSSELL, James M; RASKIN, Joel et al.The Journal of clinical psychiatry. 2007, Vol 68, Num 4, pp 518-524, issn 0160-6689, 7 p.Article

  • Page / 2